The burden of childhood cancer in Mexico: Implications for low- and middle-income countries-Reference-Cited by-同舟云学术

The burden of childhood cancer in Mexico: Implications for low- and middle-income countries

Published:2016-12-01 Issue:6 Volume:64 Page:e26366
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Rivera-Luna Roberto¹²,Zapata-Tarres Marta³,Shalkow-Klincovstein Jaime²,Velasco-Hidalgo Liliana³,Olaya-Vargas Alberto⁴,Finkelstein-Mizrahi Nicole⁵,Cárdenas-Cardós Rocío³,Aguilar-Ortiz Marco R.³

Affiliation:

1. Division of Pediatric Hem/Oncology; National Institute of Pediatrics (NIP); Mexico City Mexico

2. Program of the National Council for the Prevention and Treatment of Childhood Cancer; CENSIA; Mexico City Mexico

3. Department of Pediatric Oncology; National Institute of Pediatrics (NIP); Mexico City Mexico

4. Bone Marrow Transplant Unit; National Institute of Pediatrics (NIP); Mexico City Mexico

5. General Direction of Development of Health Services; Office of the Fund for Protection Against Catastrophic Expenses for Childhood Cancer from the Popular Medical Insurance; Mexico City Mexico

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference87 articles.

1. Variaciones trascendentes de la mortalidad por edades en México;la Loza;Salud Pública de México,1977

2. Mortality pattern in childhood cancer in Mexico;Abdullaev;Arch Med Res,2000

3. Health security and disease control: lessons from Mexico;Frenk;Vaccine,2011

4. Globalization and infectious diseases;Frenk;Infect Dis Clin North Am,2011

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming challenges to reduce time to antibiotic therapy in febrile neutropenic children: insights from a Mexican center;Hematology, Transfusion and Cell Therapy;2024-08

2. Factors Influencing Mortality in Children with Central Nervous System Tumors: A Cohort Study on Clinical Characteristics and Genetic Markers;Genes;2024-04-09

3. IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia;Frontiers in Oncology;2024-04-03

4. International Society of Paediatric Oncology (SIOP) Global Mapping Programme: Latin American Society of Pediatric Oncology (SLAOP) country‐level report;Pediatric Blood & Cancer;2024-03-31

5. Securing access to a comprehensive diagnostic panel for children with suspected acute lymphoblastic leukemia: Results from the Mexico in Alliance with St. Jude “Bridge Project”;Frontiers in Oncology;2024-01-15